Aprepitant did not modify global disease activity in cutaneous T cell lymphomas.
This article is protected by copyright. All rights reserved.
PMID: 29352481 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Maroñas-Jiménez L, Ortiz-Romero PL Tags: Br J Dermatol Source Type: research
More News: Brain | Cutaneous T cell lymphoma | Dermatology | Lymphoma | Neurology | Skin | T-cell Lymphoma | UK Health